Disease or Syndrome: Adenovirus Infections, Human

Study identifies unpredicted immune responses to adenoviral COVID-19 vaccines

Researchers from the University of Liverpool's Center for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.